Pre-exposure prophylaxis
FDA Expands Imovax Rabies Vaccine PrEP Regimen Options
The FDA has expanded the regimen options for Sanofi’s Imovax Rabies vaccine for PrEP to include a two-dose ...
JULY 29, 2025
Yeztugo Found Effective, Safe as PrEP in Pregnancy and Lactation
Lenacapavir is safe and effective in individuals who are pregnant and breastfeeding, according to new data ...
JULY 17, 2025
Investigational Once-Monthly Oral PrEP Shows Promise in People at Low Risk for HIV
The investigational drug MK-8527 (Merck) was well tolerated in its phase 2 trial presented at IAS 2025, in Kigali, ...
JULY 17, 2025
PEPFAR Spared the Budget Axe
PEPFAR has been spared from the budget rescission package passed by the U.S. Senate and House of Representatives.
JULY 16, 2025
New WHO HIV Guidelines Recommend Lenacapavir for PrEP, Rapid HIV Tests
Lenacapavir should be one choice available for people to take as PrEP for HIV, according to new guidelines released ...
JULY 14, 2025
What Long-Acting HIV Drugs Are in the Pipeline?
Sherene Min, MD, MPH, sat down with IDSE to talk about investigational long-acting drugs in the pipeline to prevent ...
JULY 14, 2025
The Critical Role of HIV Testing And Reporting in Clinical Practice: Insights From Virology Laboratories
This Special Report discusses the role of viral load testing, the challenges in interpreting results, and best ...
JUNE 27, 2025
CDC Updates Nonoccupational Post-Exposure Prophylaxis HIV Recommendations
The CDC has issued updated recommendations for antiretroviral post-exposure prophylaxis (PEP) for nonoccupational ...
MAY 27, 2025
Breaking the Barriers To PrEP Use
Pre-exposure prophylaxis (PrEP) is a cornerstone of America’s attempt to end HIV, but only about 25% of ...
DECEMBER 12, 2022
Drug Resistance a Worthwhile Risk for PrEP
The team found evidence that demonstrated that PrEP is safe, well tolerated and able to decrease HIV transmission ...
MAY 15, 2019
USPSTF: More Screening, PrEP Needed to Reduce HIV Transmission
The USPSTF posted draft guidance on HIV screening and prevention.
NOVEMBER 21, 2018
FDA Expands Indication for Truvada for PrEP Among Adolescents
The FDA granted a new indication for Gilead's Truvada to reduce the risk for sexually acquired HIV-1 in at-risk ...
MAY 15, 2018
